VYGR Voyager Therapeutics
- 8.450
- +0.080+0.96%
Voyager Therapeutics News
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jorgensen Nathan D.
Voyager Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Jorgensen Nathan D.
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Onyia Jude
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PIERCE GLENN
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vitale Nancy
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MACKEY CATHERINE J
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hyman Steven
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Higgins Michael J
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GERAGHTY JAMES A
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Colon Grace
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 10-Q: Quarterly report
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
Voyager Therapeutics | ARS: Annual Report to Security Holders
Voyager Therapeutics | DEFA14A: Others
Voyager Therapeutics | DEF 14A: Definitive information statements
Voyager Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ferguson Toby
Analysis
Price Target
No Data
